A phase II study of S-1 and oxaliplatin as first-line therapy for patients with recurrent or metastatic gastric cancer

被引：0
|
作者：
Kim, H.
Lee, G.
Kim, H.
Lee, O.
Hwang, I.
Kang, J.
机构：
[1] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea
[2] Kangwon Natl Univ, Sch Med, Chunchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15583
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)
    Koizumi, W.
    Takiuchi, H.
    Yamada, Y.
    Boku, N.
    Fuse, N.
    Muro, K.
    Komatsu, Y.
    Tsuburaya, A.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1001 - 1005
  • [32] Phase I/II study of oxaliplatin (L-OHP) in combination with S-1 (SOX) as first-line therapy for metastatic colorectal cancer (MCRC)
    Yamada, Y.
    Ohtsu, A.
    Tahara, M.
    Doi, T.
    Kato, K.
    Hamaguchi, T.
    Shimada, Y.
    Shirao, K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 142 - 143
  • [33] A phase I/II study of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer
    Park, S. R.
    Hong, Y. S.
    Park, Y.
    Kim, N. K.
    Park, Y. L.
    Park, S. Y.
    Jung, K. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER
    Zang, D. Y.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S. S.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Kim, H. S.
    Choi, D. R.
    ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [35] Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
    Zang, D. Y.
    Lee, B. H.
    Park, H. -C.
    Song, H. H.
    Kim, H. J.
    Jung, J. Y.
    Kim, J. H.
    Kim, H. Y.
    Kwon, J. H.
    Hwang, S. W.
    Park, S. R.
    Park, C. H.
    Kim, K. O.
    Kim, M. -J.
    Jang, K. M.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 892 - 896
  • [36] A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
    J-L Lee
    Y-K Kang
    H J Kang
    K-H Lee
    D Y Zang
    B-Y Ryoo
    J G Kim
    S R Park
    W K Kang
    D B Shin
    M-H Ryu
    H M Chang
    T-W Kim
    J H Baek
    Y J Min
    British Journal of Cancer, 2008, 99 : 584 - 590
  • [37] Multicenter phase II trial of S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable colorectal cancer
    Shin, S.
    Park, Y.
    Kim, T.
    Oh, D.
    Shim, B.
    Lee, K.
    Lee, M.
    Kim, Y.
    Kim, Y.
    Ahn, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
  • [39] Phase I/II and pharmacokinetic study of combination chemotherapy with S-1 and oxaliplatin in patients with previously untreated metastatic or recurrent gastric cancer
    Park, I.
    Lee, J.
    Ryu, M.
    Chang, H.
    Kim, T.
    Sym, S.
    Lee, S.
    Jang, G.
    Bae, K.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] A PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH S-1 AND OXALIPLATIN IN PATIENTS WITH RECURRENT UNRESECTABLE OR METASTATIC BILIARY CANCER
    Jang, G.
    Kim, T. W.
    Lee, S. S.
    Sym, S. J.
    Lee, J.
    Ryu, M.
    Chang, H. M.
    Kang, Y.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 177 - 177
12345